ITCMDBv1
DiseaseID 5584

多发性肌炎

disease

NCI2016_NICHD_1602D:An inflammatory disorder affecting the muscles. It presents with symmetrical proximal muscle weakness. Complications include distal weakness, thickening skin of hands and interstitial lung disease. Ju

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Disease: 1Experiment: 1Symptom: 12Target: 12Links: 25
Arranging relationship network...

Record Fields

Scalar fields from the final disease record.

Disease Id
5584
Core Entity Id
62108
Source Entity Count
1
Preferred Name
Polymyositis
Name Cn
多发性肌炎
Name Pinyin
Duo Fa Xing Ji Yan
Name En
Polymyositis
Name Latin
Bilingual Status
complete
Disease Type
disease
Umls Disease Type
Disease or Syndrome
Disgenet Type
disease
Mesh Class
Nervous System Diseases; Musculoskeletal Diseases
Do Class
Hpo Class
Mesh Class Name
Musculoskeletal Diseases; Nervous System Diseases
Hpo Class Name
Do Class Name
Disease Definition
NCI2016_NICHD_1602D:An inflammatory disorder affecting the muscles. It presents with symmetrical proximal muscle weakness. Complications include distal weakness, thickening skin of hands and interstitial lung disease. Juvenile polymyositis is a rare early onset form of the disease.|NCI2016_NCI-GLOSS_1602D:An inflammatory disease of the muscles closest to the center of the body. It causes weakness, inability to stand, climb stairs, lift, or reach. It may also cause muscle pain and difficulty swallowing, and may affect the lungs and heart. Having polymyositis increases the risk of certain types of cancer.|NCI2016_02D:An idiopathic inflammatory disorder affecting the muscles. It presents with symmetrical proximal muscle weakness and elevated skeletal muscle enzymes.|MSH2017_2016_08_12:Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)|CSP2006:inflammation of a number of voluntary muscles simultaneously.
Version
v2
Suppressed
No

Names

Preferred names, aliases, and source labels retained in the final schema.

Name
Polymyositis
Role
preferred
Name
Polymyositis Ossificans
Role
preferred
Name
Polymyositis, Idiopathic
Role
preferred

Cross References

Trusted external identifiers retained for this final record.

Herb
HBDIS003346HBDIS005632HBDIS010182
Me Sh
D017285
Umls
C0085655
Icd10
M33.2
Sym Map
SMDE12295
Dis Ge Net
C0085655C0263984C0554591
Umls Sty
T047
Me Sh Class
C05C10
Tcmbank Disease
165931684321076

Attributes

Merged source attributes and domain-specific metadata.

Version
v2
Suppress
0
Disease Type
disease
Umls Disease Type
Disease or Syndrome
Disease Definition
NCI2016_NICHD_1602D:An inflammatory disorder affecting the muscles. It presents with symmetrical proximal muscle weakness. Complications include distal weakness, thickening skin of hands and interstitial lung disease. Juvenile polymyositis is a rare early onset form of the disease.|NCI2016_NCI-GLOSS_1602D:An inflammatory disease of the muscles closest to the center of the body. It causes weakness, inability to stand, climb stairs, lift, or reach. It may also cause muscle pain and difficulty swallowing, and may affect the lungs and heart. Having polymyositis increases the risk of certain types of cancer.|NCI2016_02D:An idiopathic inflammatory disorder affecting the muscles. It presents with symmetrical proximal muscle weakness and elevated skeletal muscle enzymes.|MSH2017_2016_08_12:Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)|CSP2006:inflammation of a number of voluntary muscles simultaneously.
Me Sh Disease Class
Nervous System Diseases; Musculoskeletal Diseases
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Musculoskeletal Diseases; Nervous System Diseases
Umls Semantic Type Name
Disease or Syndrome